Travel Health Evidence

Prebentzioa

Bidaiarien beherako: zer prebenitzen du

Profilaxia produktuek adierazten duten baino okerrago funtzionatzen du, eta gertatzen denean zer egin jakiteak gehiago garrantzia du prebenitzea baino.

Eguneratuta 2 min irakurri 29 aipamenak Emaitzen indarra 4/5

Hegazkin estu baten barrualdea, goiko armairuak eta hiru eserleku aldi berean
Aykleinman (talk) · Public domain · Wikimedia Commons

Profilaxiak zer lortzen duen

Probiotikoen profilaxia [1][3][4] eta probiotikoak rifaximinarekin alderatuz [2] egin diren meta-analiziek intzidentzian murrizketa apalak aurkitzen dituzte. Apala da funtsezko hitza: hauek arrisku erlatiboen murrizketak dira egoera arrunt batean, ez babesa.

Antibiotiko profilaxia orokorrean ez da gomendatzen bidaiari arruntentzat. Erresistentzia bultzatzen du, albo efektuak ditu, eta erresistenteak diren organismoen kolonizazioa sustatzen du, bidaiariek etxera ekartzen dituztenak — indibidualtasunaren erraztasunaren truke ordaindutako kostu populazionala.

Bidaiarien beherako arazoarentzat profilaxia

Elikagai eta ur neurriak

"Ebulletu, prestatu, aztertu edo ahaztu" gogoratzen da eta partzialki eraginkorra da — atxikimenduen ikerketek arauak arretaz jarraitzen dituzten bidaiariak oraindik ere gaixotzen direla aurkitzen dute, batez ere esposizioa ikusi ezin dituzten sukaldeetan gertatzen delako.

Itzulpen onenak: botilatuta edo tratatutako ura, hortzak barne, jatorri ezezaguneko izotza saihestea, janari beroa bero zerbitzatzea eta zuk zeuk azala kentzen duzun fruta. Eskuen higienea jaten aurretik elikagaiak saihestea baino gehiago egiten du.

Ez da bidaiarien beherako arazoa bakarrik

  • Odola aulkiaren edo tenperatura altua. Mediku laguntza bilatu, auto-tratatu beharrean.
  • Sintomak astebete baino gehiago irauten dutenak. Parasitismo kausak kontuan hartu, tratamendu desberdina behar dutenak.
  • Deshidratazio larria, batez ere haurren eta bidaiari zaharren artean.
  • Sintomak itzuli ondoren hasten direnean. Esan medikuari non egon zaren; diferentziala aldatzen du.
  • Episodio akutuen ondoren irauten duten sintomak. Post-infekziosko IBS onartua eta aztertu gabeko ondorioa da.

Azken puntu horrek arreta merezi du: gutxienez %10ek irauten duten heste sintomak garatzen dituzte infekzio baten ondoren. Zure hesteak inoiz normala ez badira itzuli bidaia baten ondoren, fenomeno onartua da eta ez duzu asmatu — ikusi gure heste-burmuin froga gunean.

Ohiko galderak

Bidaiatu aurretik probiotikoak hartu behar ditut?
Meta-analisiek murrizpen apalak aurkitzen dituzte [1][2]. Arrisku txikia, kostu txikia, itxaropen txikiak.
Antibiotikoak hartu behar ditut prebentzioz?
Oro har, ez. Erresistentziak eta ondorio kaltegarriek onura gainditzen dute ohiko bidaietan.
Loperamida erabiltzeko segurua da?
Gaixotasun larria ez denean sintomak kontrolatzeko, bai. Ekidin sukarrarekin edo gorozkietan odola dagoenean.
Zenbat iraun behar du?
Kasu gehienak egun gutxi batzuetan konpontzen dira. Astebete baino gehiago irauten badu, egin azterketa bat.
Metalezko farmazia seinalea eraikin baten horman muntatuta, Konstanzen
Gorria gotiko A alemaniar hiztun herrialdeetan farmazia marko estandarra da. JoachimKohler-HB · CC BY-SA 4.0 · Wikimedia Commons

Lotutako irakurketa

Orri honen atzean dagoen froga 16 argitalpenen ikerketa motaren arabera osaketa erakusten duen barra pilatua. 1323meta-analysis (13)review (2)other (3)
16 argitalpen, 2006–2025. Oinarri behatzaile bat da, batez ere. Gauzak batera gertatzen direla ezarri dezake; baina ez du zehazten zein den bestea eragiten duena. Iturria: orri honen aipamen zerrenda, behean.

Erreferentziak

Hemen azpiko aipamen guztiak PubMed-en edo DOI bidezko jatorrizko peer-reviewed erregistroari lotzen diote. Hemen ez dago mediku aholkurik ordezkatzeko.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review Alharbi BF, Alateek AA · Travel medicine and infectious disease · 2024 · Meta-analysis DOIPubMed 38458507
  5. Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis Fagnant HS, Isidean SD, Wilson L, et al. · Advances in nutrition (Bethesda, Md.) · 2023 · Meta-analysis DOIPubMed 36822240Full text
  6. Probiotics and rifaximin for the prevention of travelers' diarrhea: A systematic review and network meta-analysis Fan H, Gao L, Yin Z, et al. · Medicine · 2022 · Meta-analysis DOIPubMed 36221413Full text
  7. Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea Brum JM, Gibb RD, Ramsey DL, et al. · Digestive diseases and sciences · 2021 · Meta-analysis DOIPubMed 32772204Full text
  8. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  9. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  10. Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials Bae JM · Epidemiology and health · 2018 · Meta-analysis DOIPubMed 30189723Full text
  11. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  12. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials Hu Y, Ren J, Zhan M, et al. · Journal of travel medicine · 2012 · Meta-analysis DOIPubMed 23379704
  13. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis Alajbegovic S, Sanders JW, Atherly DE, et al. · Systematic reviews · 2012 · Meta-analysis DOIPubMed 22929178Full text
  14. A meta-analysis of probiotic efficacy for gastrointestinal diseases Ritchie ML, Romanuk TN · PloS one · 2012 · Meta-analysis DOIPubMed 22529959Full text
  15. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients McFarland LV · World journal of gastroenterology · 2010 · Meta-analysis DOIPubMed 20458757Full text
  16. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis Riddle MS, Arnold S, Tribble DR · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2008 · Meta-analysis DOIPubMed 18781873
  17. Meta-analysis of probiotics for the prevention of traveler's diarrhea McFarland LV · Travel medicine and infectious disease · 2007 · Meta-analysis DOIPubMed 17298915
  18. Probiotics in the prevention of traveler's diarrhea: meta-analysis Takahashi O, Noguchi Y, Omata F, et al. · Journal of clinical gastroenterology · 2007 · Meta-analysis DOIPubMed 17426480
  19. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review Riddle MS, Sanders JW, Putnam SD, et al. · The American journal of tropical medicine and hygiene · 2006 · Meta-analysis PubMed 16687698
  20. Scope and applicability of social-ecological resilience to antimicrobial resistance Wernli D, Søgaard Jørgensen P, Parmley EJ, et al. · The Lancet. Planetary health · 2023 · Review DOIPubMed 37438004
  21. Safe Living Following Solid Organ Transplantation Blair BM · The Surgical clinics of North America · 2019 · Review DOIPubMed 30471739
  22. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  23. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet. Infectious diseases · 2026 · Journal article DOIPubMed 41412141
  24. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021 Rautalin I, Volovici V, Stark BA, et al. · JAMA neurology · 2025 · Journal article DOIPubMed 40406922Full text
  25. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  26. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  27. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092928Full text
  28. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  29. Foodborne outbreaks, Austria 2007 Much P, Pichler J, Kasper SS, et al. · Wiener klinische Wochenschrift · 2009 · Journal article DOIPubMed 19280130

Orri hau automatikoki itzuli da ingelesez. Aipamenak eta zenbakiak aldatu gabe daude. Irakurri ingelesezko jatorrizkoa ezer arraro irakurtzen bada. Irakurri ingelesezko jatorrizkoa